Compound ID | 2035
Class: Quinolone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | DNA synthesis inhibitor. Binds to type II topoisomerases, gyrase and topoisomerase IV to inhibitor DNA cleavage and ligation reactions; bacterial topoisomerase inhibitor |
| Description: | Synthetic pyridopyrimidine compound, derivative of piromidic acid. Similar to nalidixic acid. Also used as K+ channel blocker. |
| Year first mentioned: | 1974 |
| Highest development stage: | Approved |
| Development status: | Withdrawn |
| Reason dropped: | Safety concerns |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/4831 |
| Guide to Pharmacology: | pipemidic acid |
| Citations: |
|